MENU
Aim higher

SOLBIO

Development of Checkpoint Kinase 1 Inhibitors and Novel Diagnostics for the Treatment of Acute Myeloid Leukemia in Humans

Start date: 
03-01-2011
Project Duration: 
23months
Technological Area: 
Biology / Biotechnology
Market Area: 
Therapeutic